drug resistance

In Vivo NCL Targeting Affects Breast Cancer Aggressiveness Through miRNA Regulation.

In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.

J Exp Med. 2013 Apr 22;
Pichiorri F, Palmieri D, De Luca L, Consiglio J, You J, Rocci A, Talabere T, Piovan C, Lagana A, Cascione L, Guan… Continue reading

Prevention and Management of Variceal Hemorrhage.

Prevention and management of variceal hemorrhage.

Int J Hepatol. 2013; 2013: 434609
Kim DH, Park JY

Variceal hemorrhage is a common and devastating complication of portal hypertension and is a leading cause of death in patients with cirrhosis. The… Continue reading

Expression of the PXR Gene in Various Types of Cancer and Drug Resistance.

Expression of the PXR gene in various types of cancer and drug resistance.

Oncol Lett. 2013 Apr; 5(4): 1093-1100
Qiao E, Ji M, Wu J, Ma R, Zhang X, He Y, Zha Q, Song X, Zhu LW, Tang J… Continue reading

Optical Coherence Tomography: Clinical Applications in Medical Practice.

Optical Coherence Tomography: Clinical Applications in Medical Practice.

Oman Med J. 2013 Mar; 28(2): 86-91
Al-Mujaini A, Wali UK, Azeem S

Optical Coherence Tomography (OCT) is a success story of scientific and technological co-operation between a physicist and a… Continue reading

A Success Story: Togo Is Moving Toward Becoming the First Sub-Saharan African Nation to Eliminate Lymphatic Filariasis Through Mass Drug Administration and Countrywide Morbidity Alleviation.

A Success Story: Togo Is Moving toward Becoming the First Sub-Saharan African Nation to Eliminate Lymphatic Filariasis through Mass Drug Administration and Countrywide Morbidity Alleviation.

PLoS Negl Trop Dis. 2013 Apr; 7(4): e2080
Sodahlon YK, Dorkenoo AM, Morgah K,… Continue reading

Antibiotic Resistance and Carriage Class 1 and 2 Integrons in Clinical Isolates of Acinetobacter Baumannii From Tehran, Iran.

Antibiotic resistance and carriage class 1 and 2 integrons in clinical isolates of Acinetobacter baumannii from Tehran, Iran.

Asian Pac J Trop Biomed. 2013 Feb; 3(2): 140-145
Mirnejad R, Mostofi S, Masjedian F, Fooladi AA

To investigate antibiotic resistance… Continue reading

Luteolin Is a Novel P90 Ribosomal S6 Kinase (RSK) Inhibitor That Suppresses Notch4 Signaling by Blocking the Activation of Y-Box Binding Protein-1 (YB-1).

Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1).

Oncotarget. 2013 Feb; 4(2): 329-45
Reipas KM, Law JH, Couto N, Islam S, Li Y, Li… Continue reading

Optimization of Drug Delivery Systems for Intraperitoneal Therapy to Extend the Residence Time of the Chemotherapeutic Agent.

Optimization of drug delivery systems for intraperitoneal therapy to extend the residence time of the chemotherapeutic agent.

ScientificWorldJournal. 2013; 2013: 720858
De Smet L, Ceelen W, Remon JP, Vervaet C

Intraperitoneal (IP) chemotherapy is an effective way of treating… Continue reading

Structural Evidence for a Bifurcated Mode of Action in the Antibody-Mediated Neutralization of Hepatitis C Virus.

Structural evidence for a bifurcated mode of action in the antibody-mediated neutralization of hepatitis C virus.

Proc Natl Acad Sci U S A. 2013 Apr 15;
Deng L, Zhong L, Struble E, Duan H, Ma L, Harman C, Yan… Continue reading

Re-Directing an Alkylating Agent to Mitochondria Alters Drug Target and Cell Death Mechanism.

Re-directing an alkylating agent to mitochondria alters drug target and cell death mechanism.

PLoS One. 2013; 8(4): e60253
Mourtada R, Fonseca SB, Wisnovsky SP, Pereira MP, Wang X, Hurren R, Parfitt J, Larsen L, Smith RA, Murphy MP, Schimmer… Continue reading